A good set of FY19 results from Eurofins Scientific – barring the cyber-attack impact, the company performed satisfactorily against its financial targets. Its progress on the deleveraging front was also noteworthy, besides the curtailed M&A spending. Management remains confident about sustaining the positive momentum in FY20 and FY21. Regarding the Coronavirus, no material effect has been seen yet.
04 Mar 2020
Eurofins enters into FY20 with optimism
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Eurofins enters into FY20 with optimism
Eurofins Scientific SE (ESF:WBO) | 0 0 1.6% | Mkt Cap: 8,723m
- Published:
04 Mar 2020 -
Author:
Mohit Rathi -
Pages:
3
A good set of FY19 results from Eurofins Scientific – barring the cyber-attack impact, the company performed satisfactorily against its financial targets. Its progress on the deleveraging front was also noteworthy, besides the curtailed M&A spending. Management remains confident about sustaining the positive momentum in FY20 and FY21. Regarding the Coronavirus, no material effect has been seen yet.